188 related articles for article (PubMed ID: 31604453)
41. Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia.
Yao QM; Liu KY; Gale RP; Jiang B; Liu YR; Jiang Q; Jiang H; Zhang XH; Zhang MJ; Chen SS; Huang XJ; Xu LP; Ruan GR
BMC Cancer; 2016 Apr; 16():269. PubMed ID: 27067989
[TBL] [Abstract][Full Text] [Related]
42. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
43. An allele of IKZF1 (Ikaros) conferring susceptibility to childhood acute lymphoblastic leukemia protects against type 1 diabetes.
Swafford AD; Howson JM; Davison LJ; Wallace C; Smyth DJ; Schuilenburg H; Maisuria-Armer M; Mistry T; Lenardo MJ; Todd JA
Diabetes; 2011 Mar; 60(3):1041-4. PubMed ID: 21270240
[TBL] [Abstract][Full Text] [Related]
44. Variation at 7p12.2 and 10q21.2 influences childhood acute lymphoblastic leukemia risk in the Thai population and may contribute to racial differences in leukemia incidence.
Vijayakrishnan J; Sherborne AL; Sawangpanich R; Hongeng S; Houlston RS; Pakakasama S
Leuk Lymphoma; 2010 Oct; 51(10):1870-4. PubMed ID: 20919861
[TBL] [Abstract][Full Text] [Related]
45. High CRLF2 expression associates with IKZF1 dysfunction in adult acute lymphoblastic leukemia without CRLF2 rearrangement.
Ge Z; Gu Y; Zhao G; Li J; Chen B; Han Q; Guo X; Liu J; Li H; Yu MD; Olson J; Steffens S; Payne KJ; Song C; Dovat S
Oncotarget; 2016 Aug; 7(31):49722-49732. PubMed ID: 27391346
[TBL] [Abstract][Full Text] [Related]
46. Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.
Churchman ML; Qian M; Te Kronnie G; Zhang R; Yang W; Zhang H; Lana T; Tedrick P; Baskin R; Verbist K; Peters JL; Devidas M; Larsen E; Moore IM; Gu Z; Qu C; Yoshihara H; Porter SN; Pruett-Miller SM; Wu G; Raetz E; Martin PL; Bowman WP; Winick N; Mardis E; Fulton R; Stanulla M; Evans WE; Relling MV; Pui CH; Hunger SP; Loh ML; Handgretinger R; Nichols KE; Yang JJ; Mullighan CG
Cancer Cell; 2018 May; 33(5):937-948.e8. PubMed ID: 29681510
[TBL] [Abstract][Full Text] [Related]
47. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.
Brown AL; de Smith AJ; Gant VU; Yang W; Scheurer ME; Walsh KM; Chernus JM; Kallsen NA; Peyton SA; Davies GE; Ehli EA; Winick N; Heerema NA; Carroll AJ; Borowitz MJ; Wood BL; Carroll WL; Raetz EA; Feingold E; Devidas M; Barcellos LF; Hansen HM; Morimoto L; Kang AY; Smirnov I; Healy J; Laverdière C; Sinnett D; Taub JW; Birch JM; Thompson P; Spector LG; Pombo-de-Oliveira MS; DeWan AT; Mullighan CG; Hunger SP; Pui CH; Loh ML; Zwick ME; Metayer C; Ma X; Mueller BA; Sherman SL; Wiemels JL; Relling MV; Yang JJ; Lupo PJ; Rabin KR
Blood; 2019 Oct; 134(15):1227-1237. PubMed ID: 31350265
[TBL] [Abstract][Full Text] [Related]
48. IKZF1 alterations in acute lymphoblastic leukemia: The good, the bad and the ugly.
Vairy S; Tran TH
Blood Rev; 2020 Nov; 44():100677. PubMed ID: 32245541
[TBL] [Abstract][Full Text] [Related]
49. Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population.
Svyatova G; Boranbayeva R; Berezina G; Manzhuova L; Murtazaliyeva A
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2653-2666. PubMed ID: 37642051
[TBL] [Abstract][Full Text] [Related]
50. It's ALL in the Family: IKZF1 and Hereditary Leukemia.
Kamihara J; Shimamura A
Cancer Cell; 2018 May; 33(5):798-800. PubMed ID: 29763621
[TBL] [Abstract][Full Text] [Related]
51. IKZF1 deletion is an independent prognostic marker in childhood B-cell precursor acute lymphoblastic leukemia, and distinguishes patients benefiting from pulses during maintenance therapy: results of the EORTC Children's Leukemia Group study 58951.
Clappier E; Grardel N; Bakkus M; Rapion J; De Moerloose B; Kastner P; Caye A; Vivent J; Costa V; Ferster A; Lutz P; Mazingue F; Millot F; Plantaz D; Plat G; Plouvier E; Poirée M; Sirvent N; Uyttebroeck A; Yakouben K; Girard S; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2015 Nov; 29(11):2154-61. PubMed ID: 26050650
[TBL] [Abstract][Full Text] [Related]
52. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.
Burmeister T; Bartels G; Gröger D; Trautmann H; Schwartz S; Lenz K; Tietze-Bürger C; Viardot A; Wäsch R; Horst HA; Reinhardt R; Gökbuget N; Hoelzer D; Kneba M; Brüggemann M
Haematologica; 2014 Feb; 99(2):e23-5. PubMed ID: 24497567
[No Abstract] [Full Text] [Related]
53. DPYD gene polymorphisms are associated with risk and chemotherapy prognosis in pediatric patients with acute lymphoblastic leukemia.
Zhao XQ; Cao WJ; Yang HP; Yang XW; Tang P; Sun L; Gao X
Tumour Biol; 2016 Aug; 37(8):10393-402. PubMed ID: 26846104
[TBL] [Abstract][Full Text] [Related]
54. Intensifying Treatment of Childhood B-Lymphoblastic Leukemia With IKZF1 Deletion Reduces Relapse and Improves Overall Survival: Results of Malaysia-Singapore ALL 2010 Study.
Yeoh AEJ; Lu Y; Chin WHN; Chiew EKH; Lim EH; Li Z; Kham SKY; Chan YH; Abdullah WA; Lin HP; Chan LL; Lam JCM; Tan PL; Quah TC; Tan AM; Ariffin H
J Clin Oncol; 2018 Sep; 36(26):2726-2735. PubMed ID: 30044693
[TBL] [Abstract][Full Text] [Related]
55. The impact of IKZF1 deletion on the prognosis of acute lymphoblastic leukemia: an updated meta-analysis.
Jia M; Wang ZJ; Li JY; Yang SL; Zhao HZ; Cheng YP; Luo ZB; Tang YM
Cancer Biomark; 2014; 14(6):493-503. PubMed ID: 25335741
[TBL] [Abstract][Full Text] [Related]
56. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
57. IKZF3 polymorphisms contribute to the increased risk of acute lymphoblastic leukemia in children.
Yang X; Yang L; Luo A; Liu S; Zhang X; Liu X; Liu X; Luo A; Cai M; Yan Y; Wu X; Huang K; Xu L; Jiang H
Cancer; 2024 Mar; 130(6):973-984. PubMed ID: 38018448
[TBL] [Abstract][Full Text] [Related]
58. Broad phenotypic spectrum of germ line 7p12.1 microdeletions encompassing the IKZF1 gene includes predisposition to acute lymphoblastic leukemia.
Pastorczak A; Hogendorf A; Urbanska Z; Budzynska E; Jesionek-Kupnicka D; Gach A; Hawula W; Smigiel R; Skiba P; Sasiadek M; Lejman M; Constatinou M; Lipska-Ziętkiewicz BS; Mlynarski W
Genes Chromosomes Cancer; 2021 Feb; 60(2):79-87. PubMed ID: 33135230
[TBL] [Abstract][Full Text] [Related]
59. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of rare IKZF1 deletion in childhood B-cell precursor acute lymphoblastic leukemia: an international collaborative study.
Boer JM; van der Veer A; Rizopoulos D; Fiocco M; Sonneveld E; de Groot-Kruseman HA; Kuiper RP; Hoogerbrugge P; Horstmann M; Zaliova M; Palmi C; Trka J; Fronkova E; Emerenciano M; do Socorro Pombo-de-Oliveira M; Mlynarski W; Szczepanski T; Nebral K; Attarbaschi A; Venn N; Sutton R; Schwab CJ; Enshaei A; Vora A; Stanulla M; Schrappe M; Cazzaniga G; Conter V; Zimmermann M; Moorman AV; Pieters R; den Boer ML
Leukemia; 2016 Jan; 30(1):32-8. PubMed ID: 26202931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
